Baseline | 6 months | 1 year | ANOVA p-value | |
---|---|---|---|---|
Total Framingham risk | 15.6 (8.0 to 25.3) | 13.7 (6.3 to 21.6)a | 13.3 (6.3 to 20.8)a | < 0.001 |
Men (n = 36) | 23.5 (15.6 to 30) | 21.6 (15.6 to 29.4) | 18.4 (13.3 to 29.4) | 0.007 |
Women (n = 64) | 10.8 (4.7 to 18.5) | 10.0(3.9 to 15.9)a | 8.6 (4.5 to 15.9)a | 0.001 |
CVD (n = 36) | 23.5 (14.2 to 30) | 21.5 (13.7 to 27.5) | 18.5 (11.3 to 28.9) | 0.033 |
Without CVD (n = 64) | 13.5 (5.6 to 18.5) | 10 (4.1 to 18.4)a | 9.7 (4.7 to 15.9)a | < 0.001 |